Funding

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

National Institutes of Health · Grant

Overview

Supports new brain stimulation devices or substantial improvements in stimulation precision, depth or targeting for mental health disorders. Routine device updates and clinical trials are outside this exploratory development call.

Funding amount

Up to USD 275000 in direct costs over 2 years; maximum USD 200000 per year

Eligibility

Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.

Other deadlines

Next new-application deadline: 16 October 2026. Next renewal/resubmission/revision deadline, where permitted: 16 November 2026. Submit by 17:00 local time of the applicant organisation. Call expiration: 8 January 2028. This is separate from the application deadline.

Contact

National Institutes of Health · [email protected]

Keywords

Mental health